Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Update on hematopoietic stem cell gene transfer using non-human primate models.

Hu J, Dunbar CE.

Curr Opin Mol Ther. 2002 Oct;4(5):482-90. Review.

PMID:
12435050
2.

Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy.

Hanazono Y, Terao K, Ozawa K.

Stem Cells. 2001;19(1):12-23. Review.

3.

[Development of gene therapy for hematopoietic stem cell using viral vectors].

Dong WJ, Zu ZX, Liu DP, Liang CC.

Yi Chuan Xue Bao. 2003 Apr;30(4):382-8. Review. Chinese.

PMID:
12812066
4.

Gene transfer into hematopoietic progenitor and stem cells: progress and problems.

Dunbar CE, Emmons RV.

Stem Cells. 1994 Nov;12(6):563-76. Review.

PMID:
7881358
5.

Modeling human hematopoietic stem cell gene therapy in nonhuman primates.

Hematti P.

Curr Hematol Rep. 2004 Jul;3(4):282-9. Review.

PMID:
15217558
6.
7.

Genetic manipulation of hematopoietic stem cells.

Larochelle A, Dunbar CE.

Semin Hematol. 2004 Oct;41(4):257-71. Review.

PMID:
15508111
8.

Murine hematopoietic stem cell transduction using retroviral vectors.

Modlich U, Schambach A, Li Z, Schiedlmeier B.

Methods Mol Biol. 2009;506:23-31. doi: 10.1007/978-1-59745-409-4_3.

PMID:
19110617
9.

Transduction of hematopoietic stem cells in humans and in nonhuman primates.

Dunbar CE, Tisdale J, Yu JM, Soma T, Zujewski J, Bodine D, Sellers S, Cowan K, Donahue R, Emmons R.

Stem Cells. 1997;15 Suppl 1:135-9; discussion 139-40. Review.

10.

Advances in retroviral transduction of hematopoietic stem cells for the gene therapy of atherosclerosis.

Gough PJ, Raines EW.

Curr Opin Lipidol. 2003 Oct;14(5):491-7. Review.

PMID:
14501588
11.

Gene delivery to hematopoietic stem cells using lentiviral vectors.

Miyoshi H.

Methods Mol Biol. 2004;246:429-38.

PMID:
14970608
12.

Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model.

Shi PA, Hematti P, von Kalle C, Dunbar CE.

Oncogene. 2002 May 13;21(21):3274-83. Review.

13.

Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose.

Li Z, Schwieger M, Lange C, Kraunus J, Sun H, van den Akker E, Modlich U, Serinsöz E, Will E, von Laer D, Stocking C, Fehse B, Schiedlmeier B, Baum C.

Exp Hematol. 2003 Dec;31(12):1206-14.

PMID:
14662326
14.

Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors.

Haviernik P, Bunting KD.

Curr Gene Ther. 2004 Sep;4(3):263-76. Review.

PMID:
15384940
15.

Current status of retroviral vector mediated gene transfer into human hematopoietic stem cells.

Elwood NJ, Smith CA.

Leuk Lymphoma. 2001 Mar;41(1-2):1-18. Review.

PMID:
11342353
16.

Genetic manipulation of primate embryonic and hematopoietic stem cells with simian lentivirus vectors.

Hanazono Y, Asano T, Ueda Y, Ozawa K.

Trends Cardiovasc Med. 2003 Apr;13(3):106-10. Review.

PMID:
12691674
18.

Progress toward vector design for hematopoietic stem cell gene therapy.

Hawley RG.

Curr Gene Ther. 2001 May;1(1):1-17. Review.

PMID:
12109133
19.

Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency.

Heim DA, Dunbar CE.

Immunol Rev. 2000 Dec;178:29-38. Review.

PMID:
11213804
20.

Supplemental Content

Support Center